IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the ...

More than eight in ten of users of GLP-1 drugs in the US experienced “major changes” in their food and beverage preferences ...

Icahn continues to favor dividend reinvestment in IEP despite recent dividend cuts. See an update on Q1 2025 portfolio, key ...

Shares of International Flavors & Fragrances Inc. IFF rallied 1.25% to $76.66 Tuesday, on what proved to be an all-around ...

Ingredient suppliers are investing in new facilities to further innovation for today’s manufacturers as well as increase ...

GLP-1 drugs alter taste perception… and commonly disrupt the perception of sweetness, bitterness, fatty foods and even ...

Fintel reports that on June 4, 2025, Tigress Financial initiated coverage of International Flavors & Fragrances (NYSE:IFF) ...

The firm cited overall industry trends, strategic investments, and a broad product portfolio as critical drivers for the ...

The Emmy-winning actress executive-produced the documentary ‘October H8TE,’ which chronicles the alarming rise of ...

With the theme of "Collaboration and Connectivity Between Hubei and Hong Kong," the summit co-hosted by the IFF Sci-tech ...

Researchers at the Fraunhofer Institute for Factory Operation and Automation IFF have developed cognitive robot capabilities ...

The stock's fall snapped a two-day winning streak.